Link:
Highlights
• High doses of THC produce nausea-induced conditioned gaping.
• THC-induced conditioned gaping was mediated by its action on the CB1 receptor.
• 10 mg/kg THC produced upregulation of genes related to the 2-AG degrading enzyme, MAGL in the hypothalamus.
• High doses of THC may produce stress-induced nausea by dysregulation of endocannabinoid function in the hypothalamus.
Abstract
Δ9-tetrahydracannabinol (THC) is recognized as an effective treatment for nausea and vomiting via its action on the cannabinoid 1 (CB1) receptor. Paradoxically, there is evidence that THC can also produce nausea and vomiting. Using the conditioned gaping model of nausea in rats, we evaluated the ability of several doses of THC (0.0, 0.5, 5 and 10 mg/kg, i.p.) to produced conditioned gaping reactions. We then investigated the ability of the CB1 receptor antagonist, rimonabant, to block the establishment of THC-induced conditioned gaping. Real-time polymerase chain reaction (RT-PCR) was then used to investigate changes in endocannabinoid related genes in various brain regions in rats chronically treated with vehicle (VEH), 0.5 or 10 mg/kg THC. THC produced dose-dependent gaping, with 5 and 10 mg/kg producing significantly more gaping reactions than VEH or 0.5 mg/kg THC, a dose known to have anti-emetic properties. Pre-treatment with rimonabant reversed this effect, indicating that THC-induced conditioned gaping was CB1 receptor mediated. The RT-PCR analysis revealed an upregulation of genes for the degrading enzyme, monoacylglycerol lipase (MAGL), of the endocannabinoid, 2-arachidolyl glycerol (2-AG), in the hypothalamus of rats treated with 10 mg/kg THC. No changes in the expression of relevant genes were found in nausea (interoceptive insular cortex) or vomiting (dorsal vagal complex) related brain regions. These findings support the hypothesis that THC-induced nausea is a result of a dysregulated hypothalamic-pituitary-adrenal axis leading to an overactive stress response.
Keywords
Delta9-tetrahydracannabinol Conditioned gaping Endocannabinoid system Hypothalamus Nausea.
___________________________________________________________________________________
Interested in cutting-edge neuroscience research? Tired of exciting information being hidden behind those pesky paywalls? Introducing the First-Person Science Podcast: The 1st and only podcast dedicated to in-depth exploration of neuroscience research articles with first-hand perspectives and narratives from the authors themselves.
FPS introduces a new way to discover and engage with neuroscience research. We aim to break-down barriers to science communication by explaining jargon and complicated concepts in entertaining and succinct ways in a ‘journal club’ style to encourage collaboration and discussion between scientists and the public, alike.
In each episode, a scientist joins the show to speak about their recent ‘first-author’ manuscript. We walk viewers through each figure “1 bar graph at a time” using panel-to-panel summaries with video and visual illustrations to aid understanding of complex topics. View all figures and aspects of the research articles on our YT channel: youtube.com/firstpersonsciencepodcast
Listeners can expect to learn cool facts and get a general background for everything related to the episode's journal article through a visually immersive ‘journal club’ approach to the podcast, Ft. narratives and first-person perspectives from the authors/scientists themselves. It's a fine line to manage, but we're doing our best! And the more feedback from people from all levels of background/understanding, the better!
Listen to our podcast on itunes, spotify, or wherever you get your podcasts. Direct audio download link:
RSS Feed:
Follow us on Twitter to stay up to date on the latest research: @firstpersonsci
Facebook:
Instagram:
Interested in increasing exposure for your published research? Curious about becoming involved with the show? Email us: firstpersonsciencepod@gmail.com.
Cheers and keep on reading!
0 Comments